Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Anti-Coagulation Therapy on Patient With Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

NCT05892042 is registered in ClinicalTrials.gov with Jilin University as lead sponsor.

NCT NCT05892042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05892042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Anti-Coagulation Therapy on Patient With Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
Lead sponsor
Jilin University
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2023
Completion date
December 1, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular thrombus, st-segment elevation myocardial infarction (stemi)